These metabolites or extracts trigger ferroptosis mainly by targeting ACSL4 in the lipid metabolism pathway, which may improve the therapeutic effects on cancer when combined with chemotherapy or targeted therapy. The gene discussed is ACSL4; the disease is cancer.